IL245917B - Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use - Google Patents
Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and useInfo
- Publication number
- IL245917B IL245917B IL245917A IL24591716A IL245917B IL 245917 B IL245917 B IL 245917B IL 245917 A IL245917 A IL 245917A IL 24591716 A IL24591716 A IL 24591716A IL 245917 B IL245917 B IL 245917B
- Authority
- IL
- Israel
- Prior art keywords
- omega
- alpha
- preparation
- methods
- solid forms
- Prior art date
Links
- -1 di-substituted dihydroxy cyclopentyl compound Chemical class 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915575P | 2013-12-13 | 2013-12-13 | |
| PCT/US2014/070156 WO2015089475A1 (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL245917A0 IL245917A0 (en) | 2016-08-02 |
| IL245917B true IL245917B (en) | 2021-06-30 |
Family
ID=52282957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL245917A IL245917B (en) | 2013-12-13 | 2016-05-30 | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use |
| IL283810A IL283810A (en) | 2013-12-13 | 2021-06-08 | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL283810A IL283810A (en) | 2013-12-13 | 2021-06-08 | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9353079B2 (enExample) |
| EP (1) | EP3080096A1 (enExample) |
| JP (2) | JP2016539994A (enExample) |
| KR (1) | KR20160097310A (enExample) |
| CN (1) | CN105814033B (enExample) |
| AU (1) | AU2014361794B2 (enExample) |
| BR (1) | BR112016013594A8 (enExample) |
| CA (1) | CA2933556A1 (enExample) |
| CL (2) | CL2016001448A1 (enExample) |
| IL (2) | IL245917B (enExample) |
| MX (1) | MX2016007717A (enExample) |
| RU (1) | RU2730520C2 (enExample) |
| SA (1) | SA516371307B1 (enExample) |
| SG (2) | SG11201604787SA (enExample) |
| UA (1) | UA121108C2 (enExample) |
| WO (1) | WO2015089475A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US10765629B2 (en) * | 2017-07-25 | 2020-09-08 | Allergan, Inc. | Solid complex, preparations and uses thereof |
| US20230338194A1 (en) * | 2020-01-29 | 2023-10-26 | Kci Licensing, Inc. | Mutliple fluid pathway connector with foam supports |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO143741C (no) * | 1972-07-13 | 1981-04-08 | Pfizer | Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien |
| US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| US6602900B2 (en) | 1992-09-21 | 2003-08-05 | Allergan, Inc. | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US6124344A (en) * | 1993-12-28 | 2000-09-26 | Allergan Sales, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| DE69613693T2 (de) * | 1995-05-18 | 2002-05-16 | Allergan Sales, Inc. | 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes |
-
2014
- 2014-12-12 MX MX2016007717A patent/MX2016007717A/es unknown
- 2014-12-12 SG SG11201604787SA patent/SG11201604787SA/en unknown
- 2014-12-12 AU AU2014361794A patent/AU2014361794B2/en not_active Ceased
- 2014-12-12 EP EP14824284.5A patent/EP3080096A1/en not_active Withdrawn
- 2014-12-12 CA CA2933556A patent/CA2933556A1/en not_active Abandoned
- 2014-12-12 JP JP2016538513A patent/JP2016539994A/ja active Pending
- 2014-12-12 KR KR1020167018489A patent/KR20160097310A/ko not_active Ceased
- 2014-12-12 CN CN201480067663.3A patent/CN105814033B/zh not_active Expired - Fee Related
- 2014-12-12 SG SG10201709702UA patent/SG10201709702UA/en unknown
- 2014-12-12 RU RU2016123446A patent/RU2730520C2/ru active
- 2014-12-12 UA UAA201606260A patent/UA121108C2/uk unknown
- 2014-12-12 BR BR112016013594A patent/BR112016013594A8/pt not_active IP Right Cessation
- 2014-12-12 WO PCT/US2014/070156 patent/WO2015089475A1/en not_active Ceased
- 2014-12-12 US US14/569,210 patent/US9353079B2/en active Active
-
2016
- 2016-05-05 US US15/147,700 patent/US20170087163A1/en not_active Abandoned
- 2016-05-30 IL IL245917A patent/IL245917B/en active IP Right Grant
- 2016-06-10 CL CL2016001448A patent/CL2016001448A1/es unknown
- 2016-06-13 SA SA516371307A patent/SA516371307B1/ar unknown
-
2019
- 2019-02-22 CL CL2019000471A patent/CL2019000471A1/es unknown
- 2019-12-23 JP JP2019231685A patent/JP2020073513A/ja active Pending
-
2021
- 2021-06-08 IL IL283810A patent/IL283810A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2730520C2 (ru) | 2020-08-24 |
| US9353079B2 (en) | 2016-05-31 |
| CN105814033A (zh) | 2016-07-27 |
| UA121108C2 (uk) | 2020-04-10 |
| CA2933556A1 (en) | 2015-06-18 |
| AU2014361794A1 (en) | 2016-06-16 |
| AU2014361794B2 (en) | 2019-04-04 |
| CN105814033B (zh) | 2019-10-25 |
| CL2016001448A1 (es) | 2017-03-03 |
| IL245917A0 (en) | 2016-08-02 |
| EP3080096A1 (en) | 2016-10-19 |
| SG11201604787SA (en) | 2016-07-28 |
| US20150166504A1 (en) | 2015-06-18 |
| IL283810A (en) | 2021-07-29 |
| BR112016013594A8 (pt) | 2020-05-19 |
| JP2016539994A (ja) | 2016-12-22 |
| US20170087163A1 (en) | 2017-03-30 |
| SA516371307B1 (ar) | 2018-10-04 |
| KR20160097310A (ko) | 2016-08-17 |
| BR112016013594A2 (enExample) | 2017-08-08 |
| SG10201709702UA (en) | 2018-01-30 |
| WO2015089475A1 (en) | 2015-06-18 |
| MX2016007717A (es) | 2016-09-09 |
| CL2019000471A1 (es) | 2019-07-12 |
| JP2020073513A (ja) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256625A (en) | Antibodies to cd40 with increased agonistic activity | |
| IL261602A (en) | CD40 antibodies with increased agonistic activity | |
| IL283810A (en) | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use | |
| GB201302014D0 (en) | Use of an anode catalyst layer | |
| SG11201703356TA (en) | Management of medication preparation with dynamic processing | |
| ZA201602970B (en) | Process for the preparation of iopamidol | |
| PT3071247T (pt) | Dispositivo para a construção de pele | |
| IL245474B (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
| PL3030484T3 (pl) | Dynamicznie pozycjonowany statek | |
| IL245476B (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| ZA201603457B (en) | Novel method for the synthesis of agomelatine | |
| EP3065726A4 (en) | Creatine analogs and the use thereof | |
| EP2970319A4 (en) | 6-ACETYLMORPHINE ANALOGUE AND METHOD FOR THE SYNTHESIS AND USE | |
| HUE040536T2 (hu) | Eljárás halogén-N,N-dimetilbenzilaminok elõállítására | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| ZA201504080B (en) | Combination medicament comprising phenylephrine and paracetamol | |
| GB201323123D0 (en) | Method for the preparation of biopolymers | |
| GB2510444B (en) | Combination of phenylephrine and paracetamol | |
| ITMI20130605A1 (it) | Procedimento per la preparazione di composti benzoeterodiazolici disostituiti con gruppi benzoditiofenici | |
| SG11201700375QA (en) | Stabilized rhenium-based heterogeneous catalyst and use thereof | |
| TH1401004311B (th) | วิธีการสำหรับการผลิตวัตถุขึ้นรูปด้วยโฟมและวัตถุขึ้นรูปด้วยโฟม | |
| IL246188B (en) | A process for the preparation of tiacomycin | |
| CO6990721A2 (es) | Proceso para la preparación de análogos de magnolol | |
| GB201306040D0 (en) | Biocontrol activity surface | |
| TWM475359U (en) | Improved structure of album |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |